Presence of human epidermal growth factor in human cerebrospinal fluid. 1982

Y Hirata, and M Uchihashi, and H Nakajima, and T Fujita, and S Matsukura

Human epidermal growth factor (gEGF), a potent stimulator of the growth of many tissues in culture, has been isolated from human urine and subsequently identified in many human biological fluids. We have partially purified and characterized hEGF-like substance(s) from human cerebrospinal fluid (CSF) and determined the concentrations of immunoreactive (IR) hEGF in CSF obtained from patients with a variety of neurological diseases. Competitive binding curves generated by the CSF samples appeared to be parallel to standard hEGF both in RIA and radioreceptor assays using human placental membrane. Sephadex G-50 gel exclusion chromatography of the CSF extract revealed a single peak of IR-hEGF which coeluted with standard hEGF. The apparent mol wt of the CSF hEGF-like substances(s) was estimated to be 8000 by sodium dodecyl sulfate poplyacrylamide gel electrophoresis, and its approximate pI was 4.5 as determined by isoelectric focusing. The concentrations of IR-hEGF in CSF from patients with pituitary and brain tumors and radiculomyelopathy were significantly higher than those from control subjects, while neither patients with hydrocephalus nor encephalomeningitis had CSF IR-hEGF levels statistically different from the control subjects. The presence of hEGF-like substance(s) in human CSF suggests that it may play an important physiological role in the function of the human nervous tissues but does not provide any evidence of its source.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007525 Isoelectric Focusing Electrophoresis in which a pH gradient is established in a gel medium and proteins migrate until they reach the site (or focus) at which the pH is equal to their isoelectric point. Electrofocusing,Focusing, Isoelectric
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D002493 Central Nervous System Diseases Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord. CNS Disease,Central Nervous System Disease,Central Nervous System Disorder,CNS Diseases,Central Nervous System Disorders
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002850 Chromatography, Gel Chromatography on non-ionic gels without regard to the mechanism of solute discrimination. Chromatography, Exclusion,Chromatography, Gel Permeation,Chromatography, Molecular Sieve,Gel Filtration,Gel Filtration Chromatography,Chromatography, Size Exclusion,Exclusion Chromatography,Gel Chromatography,Gel Permeation Chromatography,Molecular Sieve Chromatography,Chromatography, Gel Filtration,Exclusion Chromatography, Size,Filtration Chromatography, Gel,Filtration, Gel,Sieve Chromatography, Molecular,Size Exclusion Chromatography

Related Publications

Y Hirata, and M Uchihashi, and H Nakajima, and T Fujita, and S Matsukura
February 1985, The Journal of clinical endocrinology and metabolism,
Y Hirata, and M Uchihashi, and H Nakajima, and T Fujita, and S Matsukura
November 1986, Journal of neurology,
Y Hirata, and M Uchihashi, and H Nakajima, and T Fujita, and S Matsukura
August 1998, Human reproduction (Oxford, England),
Y Hirata, and M Uchihashi, and H Nakajima, and T Fujita, and S Matsukura
November 1988, Gastroenterology,
Y Hirata, and M Uchihashi, and H Nakajima, and T Fujita, and S Matsukura
August 1989, Investigative ophthalmology & visual science,
Y Hirata, and M Uchihashi, and H Nakajima, and T Fujita, and S Matsukura
July 1983, The Journal of clinical endocrinology and metabolism,
Y Hirata, and M Uchihashi, and H Nakajima, and T Fujita, and S Matsukura
October 1987, Psychiatry research,
Y Hirata, and M Uchihashi, and H Nakajima, and T Fujita, and S Matsukura
January 1978, The Mount Sinai journal of medicine, New York,
Y Hirata, and M Uchihashi, and H Nakajima, and T Fujita, and S Matsukura
May 1992, Nippon Ganka Gakkai zasshi,
Y Hirata, and M Uchihashi, and H Nakajima, and T Fujita, and S Matsukura
December 1989, BioFactors (Oxford, England),
Copied contents to your clipboard!